These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31156476)

  • 41. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
    McIntyre RS; Loft H; Christensen MC
    Neuropsychiatr Dis Treat; 2021; 17():575-585. PubMed ID: 33654400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-Reported Graphic Personal and Social Performance Scale (SRG-PSP) for measuring functionality in patients with bipolar disorder.
    Mei Bai Y; Li CT; Chen MH; Kuang Yang Y
    J Affect Disord; 2017 Jun; 215():256-262. PubMed ID: 28343053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
    Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
    Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder.
    Cao Y; Li W; Shen J; Malison RT; Zhang Y; Luo X
    Asia Pac Psychiatry; 2013 Dec; 5(4):276-83. PubMed ID: 23857826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials.
    Gao S; Xie X; Fan L; Zhang D
    Exp Ther Med; 2023 Nov; 26(5):515. PubMed ID: 37840562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A higher baseline somatization score at sea level as an independent predictor of acute mountain sickness.
    Bian SZ; Jin J; Dong JQ; Li QN; Yu J; Tang CF; Yu SY; Zhao XH; Qin J; Huang L
    Physiol Behav; 2016 Dec; 167():202-208. PubMed ID: 27640135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand.
    Pitanupong J; Aunjitsakul W
    Qual Life Res; 2024 Feb; 33(2):399-409. PubMed ID: 37851323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of perceived social support in mothers of infants hospitalized in neonatal Intensive Care Unit.
    Kara S; Tan S; Aldemir S; Yılmaz A; Tatlı M; Dilmen U
    Hippokratia; 2013 Apr; 17(2):130-5. PubMed ID: 24376317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The correlates of stigma toward mental illness among Jordanian patients with major depressive disorder.
    Rayan A; Mahroum MH; Khasawneh A
    Perspect Psychiatr Care; 2018 Apr; 54(2):192-197. PubMed ID: 28543049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stigma towards people with mental disorders and its components - a perspective from multi-ethnic Singapore.
    Subramaniam M; Abdin E; Picco L; Pang S; Shafie S; Vaingankar JA; Kwok KW; Verma K; Chong SA
    Epidemiol Psychiatr Sci; 2017 Aug; 26(4):371-382. PubMed ID: 27018715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social support and psychological well-being in gender dysphoria: a comparison of patients with matched controls.
    Davey A; Bouman WP; Arcelus J; Meyer C
    J Sex Med; 2014 Dec; 11(12):2976-85. PubMed ID: 25155247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between childhood trauma, personality, social support and depression in women attending general medical clinics in a low and middle-income country.
    Husain MI; Umer M; Chaudhry IB; Husain MO; Rahman R; Shakoor S; Khaliq A; Ali WM; Zaheer J; Bassett P; Mulsant BH; Chaudhry N; Husain N
    J Affect Disord; 2021 Sep; 292():526-533. PubMed ID: 34147964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life in stabilized outpatients with bipolar I disorder: Associations with resilience, internalized stigma, and residual symptoms.
    Post F; Pardeller S; Frajo-Apor B; Kemmler G; Sondermann C; Hausmann A; Fleischhacker WW; Mizuno Y; Uchida H; Hofer A
    J Affect Disord; 2018 Oct; 238():399-404. PubMed ID: 29909303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    Raison CL; Sanacora G; Woolley J; Heinzerling K; Dunlop BW; Brown RT; Kakar R; Hassman M; Trivedi RP; Robison R; Gukasyan N; Nayak SM; Hu X; O'Donnell KC; Kelmendi B; Sloshower J; Penn AD; Bradley E; Kelly DF; Mletzko T; Nicholas CR; Hutson PR; Tarpley G; Utzinger M; Lenoch K; Warchol K; Gapasin T; Davis MC; Nelson-Douthit C; Wilson S; Brown C; Linton W; Ross S; Griffiths RR
    JAMA; 2023 Sep; 330(9):843-853. PubMed ID: 37651119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination.
    van Brakel WH; Sihombing B; Djarir H; Beise K; Kusumawardhani L; Yulihane R; Kurniasari I; Kasim M; Kesumaningsih KI; Wilder-Smith A
    Glob Health Action; 2012; 5():. PubMed ID: 22826694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD).
    Papalexi E; Galanopoulos A; Roukas D; Argyropoulos I; Michopoulos I; Douzenis A; Gkolia I; Fotiadis P; Kontis D; Zervas IM
    J Affect Disord; 2022 Oct; 314():185-192. PubMed ID: 35817305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.